Sequential immune-targeted surgical therapy resulted in disease-free survival in a case with advanced renal cell carcinoma

BACKGROUND: Currently, immunotherapy is indicated for patients with metastatic RCC or unresectable RCC, but there is no indication for immunotherapy in the neoadjuvant setting. We report a case in which the combined use of nivolumab and ipilimumab and sequential TKI therapy enabled surgical treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Kenichi, Miura, Noriyoshi, Sugihara, Naoya, Funaki, Keisuke, Koyama, Kanae, Sawada, Yuichiro, Noda, Terutaka, Fukumoto, Tetsuya, Miyauchi, Yuki, Kikugawa, Tadahiko, Saika, Takashi, Matsumura, Masafumi, Hashine, Katsuyoshi, Taniwaki, Mashio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425168/
https://www.ncbi.nlm.nih.gov/pubmed/34496819
http://dx.doi.org/10.1186/s12894-021-00891-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425168/
https://www.ncbi.nlm.nih.gov/pubmed/34496819
http://dx.doi.org/10.1186/s12894-021-00891-8

Ejemplares similares